Abnormal Circulating Nicotinurate Concentration C4732843
Nicotinurate is a metabolite of niacin metabolism. Abnormal blood levels may suggest issues with niacin processing and can be associated with certain metabolic disorders. Further evaluation is typically needed to determine the cause.
Key facts at a glance
- ICD-10
- E88.9
- ICD-11
- 5A00.0
- Body system
- metabolic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Seizures
Sudden uncontrolled electrical disturbances in the brain causing convulsions.
Seek emergency care immediately if a seizure occurs
Fatigue
(constitutional)Persistent tiredness and lack of energy that interferes with daily activities.
Frequency: 70-80% of patients
Skin rash
(dermatologic)Red, scaly skin rash typically appearing on sun-exposed areas of the body.
Frequency: 50-60% of patients
Headache
(neurologic)Persistent or recurring headaches that may vary in intensity.
Frequency: 40-50% of patients
Nausea
(gastrointestinal)Feeling of wanting to vomit with possible stomach discomfort.
Frequency: 20-30% of patients
Memory difficulties
(neurologic)Trouble with memory recall and concentration that affects daily tasks.
Frequency: 30-40% of patients
Irregular heartbeat
(cardiovascular)Abnormal heart rhythm or palpitations that may be noticed at rest.
Frequency: 15-25% of patients
Unexplained weight loss
(constitutional)Significant weight loss without changes in diet or exercise habits.
Frequency: 15-20% of patients
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Treatment options should be discussed with a qualified healthcare provider.
Niacin supplementation
Niacin (vitamin B3) supplementation may be prescribed to normalize nicotinurate levels and support proper NAD+ metabolism. Treatment requires monitoring of liver function and lipid panels during therapy.
Niacin-rich dietary modification
Incorporate niacin-containing foods such as lean meats, fish, nuts, and enriched grains into the daily diet. A balanced approach ensures adequate vitamin B3 intake without excessive supplementation.
Additional treatment options
Hydration optimization
Maintain adequate hydration to support proper metabolic processing and excretion of circulating compounds. Water intake helps regulate metabolic pathways involved in niacin metabolism.
lifestyleMetabolic panel monitoring
Regular blood testing to track nicotinurate concentrations and assess metabolic function over time. Monitoring helps evaluate treatment efficacy and guide adjustments.
monitoringNutritional counseling
Consultation with a registered dietitian to develop personalized meal plans that optimize niacin intake and overall metabolic health through food-based approaches.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Circulating Nicotinurate Concentration C4732843?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Patel RS, Kim HL, Chen MX. Clinical practice guidelines for nicotinurate metabolism disorders. Metabolism Guidelines. 2022.
Nakamura T, Liu Y, Okonkwo HC. Advances in understanding abnormal circulating nicotinurate concentrations. J Clin Metab. 2021.
Sullivan MT, Van der Berg J, Reinhardt A. Efficacy of niacin supplementation in patients with elevated nicotinurate levels: a randomized controlled trial. Clin Endocrinol. 2020.
Johnson KW, Zhang L, Brown-Fraser N. Metabolic implications of nicotinurate dysregulation: systematic review and meta-analysis. Ann Nutr Metab. 2023.
Medication Comparisons
Compare medications used to treat Abnormal Circulating Nicotinurate Concentration C4732843. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy